Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield

Current Medical Research and Opinion

Volumn 28, Issue 9, 2012, Pages 1553-1560

  Deshpande, Abhishek ^a   Pasupuleti, Vinay ^b   Patel, Preethi ^c   Pant, Chaitanya ^d   Pagadala, Mangesh ^e   Hall, Geraldine ^f   Hu, Bo ^f   Jain, Anil ^f   Rolston, David D K ^g   Sferra, Thomas J ^d   Atreja, Ashish ^e  

^a NEUROLOGICAL INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Medicine Institute ^*  (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e Digestive Disease Institute   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g GEISINGER MEDICAL CENTER   (United States)

Author keywords

Bacteria; Clostridium difficile; Diagnostic yield; Hospital acquired infection; Inflammatory bowel disease

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENTERITIS; ENZYME IMMUNOASSAY; FECES ANALYSIS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

FECES; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; POLYMERASE CHAIN REACTION; PROBABILITY; RETROSPECTIVE STUDIES;

EID: 84866724584     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.717529     Document Type: Article

References (34)

1. Gerding DN, Johnson S, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77
2. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345-51
3. Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract 2011;2011:136064
4. Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008;8:777-84
5. Jarvis WR, Schlosser J, Jarvis AA, et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009;37:263-70
6. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339-44
7. Navaneethan U, Mukewar S, Venkatesh PG, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis 2012;6:330-6
8. Goldenberg SD, French GL. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect 2011;79:4-7
9. Reller ME, Alcabasa RC, Lema CA, et al. Comparison of two rapid assays for Clostridium difficile common antigen and a C difficile toxin A/B assay with the cell culture neutralization assay. Am J Clin Pathol 2010;133:107-9
10. Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of realtime polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011;53:e81-90
11. Crobach MJ, Dekkers OM, Wilcox MH, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009;15:1053-66
12. Aichinger E, Schleck CD, Harmsen WS, et al. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immu-noassay. J Clin Microbiol 2008;46:3795-7
13. Barbut F, Braun M, Burghoffer B, et al. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009;47:1276-7
14. Luo RF, Banaei N. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J Clin Microbiol 2010;48:3738-41
15. Nemat H, Khan R, Ashraf MS, et al. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol 2009;104:2035-41
16. Deshpande A, Pasupuleti V, Patel P, et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 2011;9:665-9 e1
17. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007;45:222-7
18. Snell H, Ramos M, Longo S, et al. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2004;42:4863-5
19. Manabe YC, Vinetz JM, Moore RD, et al. Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 1995;123:835-40
20. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-9
21. Debast SB, van Kregten E, Oskam KM, et al. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clin Microbiol Infect 2008;14:622-4
22. Arabi Z, Boxwalla A. Repeated stool toxin testing for diagnosing Difficile colitis is still valid. South Med J 2009;102:993-4
23. Belanger SD, Boissinot M, Clairoux N, et al. Rapid detection of Clostridium difficile in feces by real-time PCR. J Clin Microbiol 2003;41:730-4
24. Guilbault C, Labbe AC, Poirier L, et al. Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens. J Clin Microbiol 2002;40:2288-90
25. Sloan LM, Duresko BJ, Gustafson DR, et al. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008;46:1996-2001
26. van den Berg RJ, Kuijper EJ, van Coppenraet LE, et al. Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCR. Clin Microbiol Infect 2006;12:184-6
27. Deshpande A, Pasupuleti V, Pant C, et al. Potential value of repeat stool testing for Clostridium difficile stool toxin using enzyme immunoassay? Curr Med Res Opin 2010;26:2635-41
28. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55
29. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcer-ative colitis and co-existing Clostridium difficile infection. Digestive diseases and sciences 2010;55:415-20
30. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcer-ative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010;55:415-20
31. Subramanian V. Clostridium difficile and inflammatory bowel disease: implications for current clinical practice. F1000 Med Rep 2009;1(pii):25
32. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008;57:205-10
33. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011;32:932-3
34. Goldenberg SD, Price NM, Tucker D, et al. Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy? J Infect 2011;62:363-70